new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)





Similar
Filing Names

Institut Pasteur
Institut Pasteur De Lille
Institut Pasteur Korea
Institut Pasteur Of Shanghai Chinese Academy Of Sciences
Institut Pasteur And Centre National De La Recherche Scientifique
Institut Pasteur And Institut Nationale De La Recherche Medicale
Institut Pasteur And The Centre National De La Recherche Scientifique cnrs
Institut Pasteur And Inserm
Institut Pasteur And Centre National De La Recherche Scientifique cnrs
Institut Pasteur And Centre De La Recherche Scientifique
Institut Pasteur Centre National De La Recherche Scientifique And Universite Paris
Institut Pasteur And Centre Nationale De La Recherche Scientifique
Institut Pasteur De Lille ipl
Institut Pasteur Institut National De La Sante Et De La Recherche Medicale x26 Assistance Publique
Institut Pasteur Of Shanghai Cas
Institut Pasteur Du Cambodge
Institut Pasteur De Tunis
Institut Pasteur Of Shanghai
Institut Pasteur_20100114
Institut Pasteur Centre National De La Recherche Scientifique
  

Institut Pasteur patents

Recent patent applications related to Institut Pasteur. Institut Pasteur is listed as an Agent/Assignee. Note: Institut Pasteur may have other listings under different names/spellings. We're not affiliated with Institut Pasteur, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "I" | Institut Pasteur-related inventors




Date Institut Pasteur patents (updated weekly) - BOOKMARK this page
05/04/17Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infection
04/20/17Recombinant mycobacterium bovis bcg expressing antigens of the mycobacterium marinum esx-1 secretion system
04/20/17Broad range gene and genotype papillomavirus transcriptome as a biomarker of papillomavirus-associated cancer stages
04/20/17Enzyme-independent photon emission
03/30/17Methods for obtaining stem cells
03/30/17Mgmt-based obtaining high yeilds of recombinant protein expression
03/23/17Transgenic mice having a human major histocompatibility complex (mhc) phenotype, experimental uses and applications
03/16/17Production of 1-propanol
03/02/17Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereof
02/23/17Method and device for conserving viable and functional human polymorphonuclear neutrophils
02/23/17Rapid detection of the "high virulent" st-17 clone of group b streptococcus
02/09/17Chromosomal modification involving the induction of double-stranded dna cleavage and homologous recombination at the cleavage site
02/02/17Tal effector means useful for partial or full deletion of dna tandem repeats
01/26/17Leptospira immunoprotective proteins and methods of identification and use thereof
01/26/17High mast2-affinity polypeptides and uses thereof
01/05/17Use of vhh antibodies for the preparation of peptide vectors for delivering a substance of interest and their applications
12/29/16Vectors for molecule delivery to cd11b expressing cells
12/15/16Treatment of cardiac diseases with modulators of the hippo pathway
12/08/16Oligopeptide and methods for producing conjugates thereof
12/01/16Camelid single-domain antibody directed against amyloid beta and methods for producing conjugates thereof
11/24/16Peptides derived from human bplp protein, polynucleotides coding for said peptides and antibodies directed against said peptides
11/03/16Polypeptides targeting glycosylated muc2 proteins, methods of synthesis, their nucleic acids and uses thereof
10/27/16Therapeutic methods and compositions
10/06/16A molecular marker of plasmodium falciparum artemisinin resistance
09/22/16Subunit vaccine platform based on multimeric ribonucleoproteins comprising nucleoproteins of a non-segmented negative-strand rna virus as carriers of heterologous polypeptides
08/18/16Use of bacterial polysaccharides for biofilm inhibition
07/28/16Use of bacterial polysaccharides for biofilm inhibition
07/28/16Identifying molecular systems in protein sequence data
07/07/16Correlation of disease activity with clonal expansions of human papillomavirus 16-specific cd8+ t-cells in patients with severe erosive oral lichen planus
06/16/16Vaccines for serogroup x meningococcus
05/26/16Bacteriophage therapy
03/24/16Mutant cyaa polypeptides and polypeptide derivatives suitable for the delivery of immunogenic molecules into a cell
03/17/16Olfactory means useful in the diagnosis and treatment of mood depression
03/17/16Mutation within the connexin 26 gene responsible for prelingual non-syndromic deafness and detection
02/18/16Methods to obtain a novel class of gram negative bacteria antibiotics which target an unknown cell division associated protein lop1
02/11/16Recombinant measles viruses expressing epitopes of antigens of rna viruses - use for the preparation of vaccine compositions
01/21/16Mgmt-based obtaining high yeilds of recombinant protein expression
01/21/16Hmgb1 and anti-hmgb1 antibodies for the prognostic of neurological disorders
01/14/16Galactosaminogalactan comprising alpha-1-4 linked galactose and alpha-1-4 linked n-acetylgalactosamine for use in the treatment of at least one inflammatory disease
01/14/16Ob-fold used as scaffold for engineering new specific binders
12/31/15Method, device, and computer program for locating an emitting source of which measurements of emission propagation at locations different from that of the emitting source can be obtained from those locations, lacking space perception
12/17/15Use of a genetically modified infectious measles virus with enhanced pro-apoptotic properties (mv-deltac virus) in cancer therapy
12/03/15Nod2-dependent pathway of cytoprotection of stem cells
11/19/15Opiorphin for use as a psychostimulant agent
11/12/15Use of anti-fcyri and/or anti-fcyriia antibodies for treating arthritis, inflammation, thrombocytopenia and allergic shock
10/15/15Glycoconjugates and their use as potential vaccines against infection by shigella flexneri
10/15/15Therapy of cancer based on targeting adaptive, innate and/or regulatory component of the immune response
10/01/15Infectious cdna of an approved vaccine strain of measles virus, use for immunogenic compositions
09/17/15Chromosomal modification involving the induction of double-stranded dna cleavage and homologous recombination at the cleavage site
09/10/15Use of leptospira fainei serovar hurstbridge bacteria for diagnosing leptospirosis
09/03/15Compounds and methods for preventing or treating a viral infection
09/03/15Levels of cxcl 10/ip-10 forms and soluble cd26/dppiv activity as early predictive biomarkers for hiv/siv associated mucosal inflammation and progression towards aids
08/27/15Recombinant measles virus expressing chikungunya virus polypeptides and their applications
08/06/15Reverse genetics of negative-strand rna viruses in yeast
07/30/15Medicaments and methods for treating mesothelioma
07/09/15Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna
05/14/15Anellovirus genome quantification as a biomarker of immune suppression
04/23/15Novel isolated and purified strains of chikungunya virus and polynucleotides and polypeptides sequences, diagnostic and immunogenical uses thereof
04/09/15Multiplex immuno screening assay
03/12/15Cancer treatment by immunotherapy with bcg or antigenically related non-pathogenic mycobacteria
03/12/15Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infection
03/05/15Opiorphin peptide derivatives as potent inhibitors of enkephalin-degrading ectopeptidases
02/26/15Monitoring and inhibiting human immunodeficiency virus infection by modulating hmgb1 dependent triggering of hiv-1 replication and persistence
02/26/15Transgenic immunodeficient mouse expressing human sirp-alpha
02/19/15Glycoconjugates and use thereof as vaccine against shigella flexneri serotype 3a and x
Patent Packs
02/12/15Correlation of disease activity with clonal expansions of human papillomavirus 16-specific cd8+ t-cells in patients with severe erosive oral lichen planus
01/08/15Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna
01/01/15Adam12 inhibitors and their use against inflammation-induced fibrosis
12/25/14Method for preparing multiple antigen glycopeptide carbohydrate conjugates
11/27/14Peptides derived from human bplp protein, polynucleotides coding for said peptides and antibodies directed against said peptides
11/13/14Polypeptides targeting glycosylated muc2 proteins, methods of synthesis, their nucleic acids and uses thereof
10/16/14Hmgb1 and anti-hmgb1 antibodies for the prognostic of neurological disorders
08/21/14Neurovirulent strain of the west nile virus and uses thereof
08/14/14Recombinant adenylate cyclase toxin of bordetella induces t cell responses against tumoral antigens
07/24/14Variable domains of camelid heavy-chain antibodies directed against glial fibrillary acidic proteins
07/10/14Use of basic prolin-rich lacrimal gene products, such as opiorphin, as a biomarker
06/19/14Method for preparing multiple antigen glycopeptide carbohydrate conjugates
05/01/14Monitoring and inhibiting human immunodeficiency virus infection by modulating hmgb1 dependent triggering of hiv-1 replication and persistence
04/24/14Mutation within the connexin 26 gene responsible for prelingual non-syndromic deafness and detection
04/17/14Monitoring and inhibiting human immunodeficiency virus infection by modulating hmgb1 dependent triggering of hiv-1 replication and persistence
Patent Packs
03/27/14Method, probe and kit for dna in situ hybridation and use thereof
02/27/14Polynucleotides encoding mhc class i-restricted htert epitopes, analogues thereof or polyepitopes
01/30/14Compounds and methods for preventing or treating a viral infection
11/14/13Method for manufacturing an analysis substrate, and use thereof for detecting toxins
11/07/13Infectious cdna of an approved vaccine strain of measles virus, use for immunogenic compositions
06/27/13Deleted sequences in m. bovis bcg/m. bovis or m. tuberculosis, detecting mycobacteria using said sequences and vaccines
06/13/13Methods for obtaining stem cells
05/16/13Streptavidin and biotin-based antigen delivery system
05/09/13Method to increase the number of detectable photons during the imaging of a biological marker
04/11/13Dengue and west nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications
12/20/12Mutation within the connexin 26 gene responsible for prelingual non-syndromic deafness and detection
12/06/12Use of bacterial polysaccharides for biofilm inhibition
08/16/12Multivalent epitope in complex with a detection marker for the early serodiagnosis of infections
08/09/12Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infection
07/26/12Identification of virulence associated regions rd1 and rd5 leading to improve vaccine of m. bovis bcg and m. microti
07/05/12Methods of using sip-10, cd26 inhibitors and cxcr3 levels in a sample to assess clearance of infection, response to interferon therapy, and treating chronic infections
06/21/12Recombinant mycobacterium strain expressing a mycobacterial fap protein under the control of a promoter active under hypoxia and its application for cancer therapy
04/26/12Neuron generation, regeneration and protection
04/12/12Molecular typing and subtyping of salmonella by identification of the variable nucleotide sequences of the crispr loci
04/12/12Hcv-derived polypeptides and uses thereof
03/29/12Identification and characterization of racemases, definition of protein signatures, and a test for detecting d-amino acid and for screening molecules capable of inhibiting the activity of racemase, especially proline racemase
03/22/12Apobec3 mediated dna editing
03/08/12Identification and characterization of racemases, definition of protein signatures, and a test for detecting d-amino acid and for screening molecules capable of inhibiting the activity of racemase, especially proline racemase
03/01/12Mutant cyaa polypeptides and polypeptide derivatives suitable for the delivery of immunogenic molecules into a cell
02/09/12Use of basic prolin-rich lacrimal gene products, such as opiorphin, as a biomarker
01/12/12Early detection of flaviviruses using the ns1 glycoprotein
12/22/11Reverse genetics of negative-strand rna viruses in yeast
12/15/11Use of a dead-box rna helicase for inducing cytokine production
11/24/11Novel hcv core+1 protein, methods for diagnosis of hcv infections, prophylaxis, and for screening of anti-hcv agents
10/06/11Peptides derived from human bplp protein, polynucleotides coding for said peptides and antibodies directed against said peptides
Social Network Patent Pack
09/22/11Monitoring and inhibiting human immunodeficiency virus infection by modulating hmgb1 dependent triggering of hiv-1 replication and persistence
09/15/11Clostridium toxin, and process for the preparation of immunogenic composition
07/28/11Nucleotide sequence encoding a modulator of nf-kb
07/28/11Molecular signature of liver tumor grade and use to evaluate prognosis and therapeutic regimen
07/21/11Opiorphin for use as a psychostimulant agent
06/30/11Cell-based screening assay to identify molecules that stimulate ifn-alpha/beta target genes
06/30/11Crystal structure of the ccz-lz domain of nemo
06/16/11Transgenic mice having a human major histocompatibility complex (mhc) phenotype, experimental uses and applications
05/26/11Opiorphin peptide derivatives as potent inhibitors of enkephalin-degrading ectopeptidases
05/05/11Use of the innate immunity gene oasl for preventing or treating infection with negative strand rna viruses
Patent Packs
04/21/11Mutations in the ns5b protein of the hcv
03/17/11Transgenic mice having a human major histocompatibility complex (mhc) phenotype, experimental uses and applications
02/24/11Upregulation of rack-1 in melanoma and its use as a marker
02/17/11Methods for detecting virulent plasmodium, for evaluating plasmodium virulence, and for screening new drugs employing the 3'utr of plasmodium sub2 and the plasmodium sub2 serine protease
02/10/11Cxcl12 gamma a chemokine and uses thereof
02/03/11Methods of screening of pp1-interacting polypeptides or proteins, peptides inhibiting pp1c binding to bcl-2 proteins, bcl-xl and bcl-w, and uses thereof
01/27/11Single cell based reporter assay to monitor gene expression patterns with high spatio-temporal resolution
01/06/11Hybrid tetnus toxoid proteins that migrate retrogradely and transynaptically into the cns
01/06/11Plasmodium falciparum antigens and their vaccine and diagnostic applications
01/06/11Differential amplification of mutant nucleic acids by pcr in a mixture of nucleic acids
12/30/10Immunogenic polypeptide isolated from mycobacterium avium subspecies paratuberculosis and uses thereof
12/23/10Targeting the histone code as a bacterial strategy for selectively modulating gene expression
11/18/10Identification of a conserved region of plasmodium falciparum msp3 targeted by biologically active antibodies
11/11/10Combinatorial production of nucleotide and nucleoside (xitp) analogues
11/04/10Medicaments and methods for treating mesothelioma
10/28/10Peptides of il-2
10/28/10Polynucleotides and their use for detecting resistance to streptogramin a or to streptogramin b and related compounds
10/07/10Polynucleotides and polypeptides involved in gestational malaria, and biological applications
10/07/10Purified polypeptide comprising or consisting of a c-terminus msp1 antigen from plasmodium falciparum carrying a glycosyl-phosphatidyl-inositol group (gpi)
09/30/10Novel synthetic peptide vaccines for hiv: the cbd epitope as an effective immunogen to elicit broadly neutralizing antibodies against hiv
09/23/10Hybrid proteins that migrate retrogradely and transynaptically into the cns
09/02/10Use of triplex structure dna in transferring nucleotide sequences
08/05/10Identification and characterization of racemases, definition of protein signatures, and a test for detecting d-amino acid and for screening molecules capable of inhibiting the activity of racemase, especially proline racemase
07/22/10Differential amplification of mutant nucleic acids by pcr in a mixture of nucleic acids
07/01/10Process for enriching basophils in a blood sample
06/24/10Monitoring and inhibiting human immunodeficiency virus infection by modulating hmgb1 dependent triggering of hiv-1 replication and persistence
06/17/10Plasmodium falciparum antigens inducing protective antibodies
06/10/10Nucleotide sequence encoding a modulator of nf-kb
05/06/10Acellular antibordetella vaccine
03/11/10Natural selection and cellular immortality
Patent Packs
02/18/10Methods of using sip-10, cd26 inhibitors and cxcr3 levels in a sample to assess clearance of infection, response to interferon therapy, and treating chronic infections
01/14/10Peptides binding the phosphatase 2a protein
01/14/10Immunodeficient mice transgenic for hla class i and hla class ii molecules and their uses
12/10/09Recombinant mycobacterium strain expressing a mycobacterial fap protein under the control of a promoter active under hypoxia and its application for cancer therapy
12/03/09Method for identifying bplp and opiorphin agonists or antagonists
12/03/09Identification and characterization of racemases, definition of protein signatures, and a test for detecting d-amino acid and for screening molecules capable of inhibiting the activity of racemase, especially proline racemase
10/29/09Identification of substances that inhibit nemo oligomerization
10/29/09Method and systems for locating a source of particle, molecule, or fragment of molecule
10/22/09Genetic variations associated with psychiatric disorders
10/08/09Opiorphin peptide derivatives as potent inhibitors of enkephalin-degrading ectopeptidases
09/10/09Hybrid tetanus toxoid proteins that migrate retrogradely and transynaptically into the cns
09/10/09Early detection of flaviviruses using the ns1 glycoprotein
08/27/09Identification of a conserved region of plasmodium falciparum msp3 targeted by biologically active antibodies
07/16/09Transcription factor arntl2 gene and expression products thereof used in the diagnosis, prevention, and treatment of type 1 diabetes
06/25/09Identification and characterization of racemases, definition of protein signatures, and a test for detecting d-amino acid and for screening molecules capable of inhibiting the activity of racemase, especially proline racemase
06/04/09Hiv recombinant vaccine
05/28/09Methods of treating neurological diseases by regulating migration of neuroblasts in the adult nervous system with tenascin-r
05/14/09Method for the diagnosis of genetic diseases by molecular combing and diagnostic kit
04/23/09Mutation within the connexin 26 gene responsible for prelingual non-syndromic deafness and detection
04/16/09Upregulation of rack-1 in melanoma and its use as a marker
Social Network Patent Pack
03/26/09Method of diagnosis/prognosis of human chronic lymphocytic leukemia comprising the profiling of lpl/adam genes
03/12/09Early detection of flaviviruses using the ns1 glycoprotein
03/05/09Nucleotide sequence encoding a modulator of nf-kb
02/26/09Use of penicillin-binding proteins or polynucleotides or antibodies thereof for preventing or treating bacterial infections
02/19/09Compositions comprising dc-sign blockers and methods of using dc-sign blockers for preventing or treating diseases of a mammal, including viral infections
01/14/10Immunodeficient mice transgenic for hla class i and hla class ii molecules and their uses
06/03/10Lentivirus pseudotyped with influenza hemagglutinin and methods of use
09/29/16Use of rapamycin as vaccine adjuvant and preparation method therefor
03/12/15Use of phosphorylation pathway-related factor in regulating function of regulatory t cell
02/12/15Component and treating viral disease
01/02/14Method for producing virus-like particle by using drosophila cell and applications thereof
05/16/13Regulatory factor of foxp3 and regulatory t cells and use thereof
05/04/17Anti-infective compounds
02/16/17Compounds for treating viral infections
06/30/16Anti-infective compounds
01/15/15Anti-infective compounds
06/05/14Anti-inflammation compounds
12/31/09Mutated immunogenic peptides derived from r9m, polynucleotides coding for same and therapeutic uses thereof
10/06/16A molecular marker of plasmodium falciparum artemisinin resistance
10/15/09Method for the production of high-level soluble human recombinant interferon alpha in e. coli and vectors useful for such a production
Social Network Patent Pack
04/20/17Influenza vaccine, composition, and methods of use
01/26/17Novel immunoadjuvant flagellin-based compounds and use thereof
06/02/16Methods and pharmaceutical compositions for the treatment of bacterial infections
04/07/16Adenylate cyclase deficient bordetella strains
02/18/16Attenuated bordetella strains
12/31/15Activation of inkt cells
09/03/15Methods and pharmaceutical compositions for the prophylactic treatment of bacterial superinfections post-influenza
08/13/15Methods and pharmaceutical compositions for the prophylactic treatment of bacterial superinfections post-influenza with invariant nkt cell agonists
07/30/15Novel recombinant bordetella strains
07/23/15Method of using attenuated bordetella strains
07/02/15Vaccine for prophylaxis or treatment of an allergen-driven airway pathology
06/18/15Marker peptides for determining the occurrence of an inflammatory state in a subject
02/12/15Native ligation process
10/16/14Fluoralkylcarbonyl-oxadiazoles
07/18/13Vaccine for prophylaxis or treatment of an allergen-driven airway pathology
05/17/12Influenza vaccine, composition, and methods of use
04/12/12Post-translation modified cardiac troponin t as a biomarker of a risk for heart failure
01/19/12Marker peptides for determining the occurrence of an inflammatory state in a subject
12/08/11The use of a non-glycanated polypeptide for treating a cancer
05/26/11Fto gene polymorphisms associated to obesity and/or type ii diabetes
04/27/17Mitochondrial non-coding rnas for predicting disease progression in heart failure and myocardial infarction patients
10/13/11Variable domains of camelid heavy-chain antibodies directed against glial fibrillary acidic proteins
04/05/12Use of proteins and peptides encoded by the genome of a novel sars-associated coronavirus strain
06/03/10Mutants of deoxycytidine kinase having extended enzymatic activity
10/06/11Polynucleotides allowing the expression and secretion of recombinant pseudo-virus containing foreign epitopes, their production, and use
04/09/09Polynucleotides allowing the expression and secretion of recombinant pseudo-virus containing foreign epitopes, their production, and use
05/10/12Recombinant plasmodium falciparum merozoite surface proteins 4 and 5 and their use
02/28/13Recombinant measles viruses expressing epitopes of antigens of rna viruses - use for the preparation of vaccine compositions
08/25/11Recombinant lentiviral vector for expression of a flaviviridae protein and applications thereof as a vaccine
06/30/11Use of the combing process for the identification of dna origins of replication
Social Network Patent Pack
08/23/12Vectors for molecule delivery to cd11b expressing cells







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Institut Pasteur in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Institut Pasteur with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';